Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients

Tools for the evaluation of COVID-19 severity would help clinicians with triage decisions, especially the decision whether to admit to ICU. The aim of this study was to evaluate SeptiCyte RAPID, a host immune response assay (Immunexpress, Seattle USA) as a triaging tool for COVID-19 patients requiri...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero, Maria Milagro, Hardy-Werbin, Max, Gonzalez-Gallardo, Soledad, Torres, Erica, Rueda, Rebeca, Hannet, Irene, Kirk, James T., Yager, Thomas D., Navalkar, Krupa, Arenas, Maria del Mar, Arietta-Aldea, Itziar, Castañeda, Silvia, Gómez-Junyent, Joan, Gómez-Zorrilla, Silvia, Guerri-Fernandez, Roberto, Sanchez-Martinez, Francisca, López-Montesinos, Immaculada, Pelegrín, Ivan, Sendra, Elena, Sorlí, Luisa, Villar-García, Judith, Bellosillo, Beatriz, Horcajada, Juan Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845827/
https://www.ncbi.nlm.nih.gov/pubmed/36653401
http://dx.doi.org/10.1038/s41598-023-28178-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845827/
https://www.ncbi.nlm.nih.gov/pubmed/36653401
http://dx.doi.org/10.1038/s41598-023-28178-y

Ejemplares similares